Serina Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	8.62	3.67	7.62	0.65	0.58	0.53
Cash & Short-Term Investments	8.62	3.67	7.62	0.65	0.58	0.53
Cash Growth	170.64%	-51.80%	1081.24%	10.45%	10.82%	-77.59%
Accounts Receivable	-	-	-	0	0.03	0.33
Total Current Assets	8.62	3.67	7.62	0.65	0.61	0.85
Total Assets	8.62	3.67	7.62	0.65	0.61	0.85
Net Cash (Debt)	8.62	3.67	7.62	0.65	0.58	0.53
Net Cash Growth	134.75%	-51.80%	1081.24%	10.45%	10.82%	-77.59%
Net Cash Per Share	0.88	0.50	1.04	0.30	0.54	0.49

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q